StockData
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc (ALXO) stock

ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.00+0.00 (+0.50%)

Close on Nov 17, 2026Market cap $138.97MP/E –Yield –

ALX Oncology operating margin

Operating margin is operating income as a percentage of revenue.

ALX Oncology's operating margin for the twelve months ending Dec 31, 2020 was -3694.0%. For fiscal 2020 it was -3694.0%, against -400.0% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-3694.0%−3294.0
FY2019Dec 31, 2019-400.0%+262.0
FY2018Dec 31, 2018-662.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2020Jun 30, 2020-2046.9%−1723.4
Q1 FY2020Mar 31, 2020-800.3%–
Q4 FY2019Dec 31, 2019-637.5%–
Q3 FY2019Sep 30, 2019-241.6%–
Q2 FY2019Jun 30, 2019-323.5%–

More ALX Oncology figures

See a number that looks wrong?